Skip to main content

Advertisement

SpringerLink
Log in

Detection of autoantibodies to multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer

  • Research Article
  • Published:
Tumor Biology

Abstract

We aimed to evaluate the immunodiagnostic values of autoantibodies to a panel of six tumor-associated antigens (TAAs) in the detection of patients with breast cancer. This study determines whether a panel of multiple TAAs would enhance antibody detection and be a useful approach in breast cancer detection and diagnosis. The panel of multiple TAAs was composed of six TAAs including Imp1, p16, Koc, survivin, cyclin B1, and c-myc full-length recombinant proteins. Enzyme-linked immunosorbent assay (ELISA) was used to detect antibodies against these six TAAs in 49 sera from patients with breast cancer, 35 sera from patients with benign breast tumor, and 38 sera from normal individuals. Antibody frequency to any individual TAA in breast cancer was variable and ranged from 12.2 to 18.4 %. With the successive addition of TAAs to a final total of six antigens, there was a stepwise increase of positive antibody reactions reaching a sensitivity of 67.3 % and a specificity of 92.2 % in breast cancer. Positive and negative likelihood ratios were 8.52 and 0.36, respectively, which showed that the clinical diagnostic value of a parallel assay of six TAAs was high. Positive and negative predictive values were, respectively, 91.7 and 68.6 %, indicating that the parallel assay of six TAAs raised the diagnostic accuracy greatly. Agreement rate and kappa value were 78.1 % and 0.57, respectively, which indicated that the observed value of this assay had a middle range of coincidence with the actual value. The data from this study further support our previous hypothesis that the detection of autoantibodies for diagnosis of a certain type of cancer can be enhanced by using a panel of several carefully selected TAAs as target antigens and a panel of multiple TAAs would be a useful approach in the detection and diagnosis of breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2013;63:11–30.

    Article  PubMed  Google Scholar 

  2. Tan EM. Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. J Clin Invest. 2001;108:1411–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Tan EM, Zhang J. Autoantibodies to tumor-associated antigens: reporters from the immune system. Immunol Rev. 2008;222:328–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Old LJ, Chen YT. New paths in human cancer serology. J Exp Med. 1998;187:1163–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Zhang JY, Chan EKL, Peng XX, Tan EM. A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma. J Exp Med. 1999;189:1101–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Nielsen J, Christiansen J, Lykke-Andersen J, Johnsen AH, Wewer UM, Nielsen FC. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol. 1999;19:1262–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Muller-Pillasch F, Lacher U, Wallrapp C, Micha A, Zimmerhackl F, Hameister H, et al. Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene. 1997;14:2729–33.

    Article  Google Scholar 

  8. Crawford LV, Pim DC, Bulbrook RD. Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer. Int J Cancer. 1982;30:403–8.

    Article  CAS  PubMed  Google Scholar 

  9. Soussi T. p53 antibodies in the sera of patients with various types of cancer: a review. Cancer Res. 2000;60:1777–88.

    CAS  PubMed  Google Scholar 

  10. Covini G, Chan EK, Nishioka M, Morshed SA, Reed SI, Tan EM. Immune response to cyclinB1 in hepatocellular carcinoma. Hepatology. 1997;25:75–80.

    Article  CAS  PubMed  Google Scholar 

  11. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997;3:917–21.

    Article  CAS  PubMed  Google Scholar 

  12. Yamamoto A, Shimizu E, Takeuchi E, Houchi H, Doi H, Bando H, et al. Infrequent presence of anti-c-Myc antibodies and absence of c-Myc oncoprotein in sera from lung cancer patients. Oncology. 1999;56:129–33.

    Article  CAS  PubMed  Google Scholar 

  13. Zhang JY, Casiano CA, Peng XX, Koziol JA, Chan EKL, Tan EM. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. Cancer Epidemiol Biomarkers Prev. 2003;12:136–43.

    CAS  PubMed  Google Scholar 

  14. Zhang JY, Megliorino R, Peng XX, Tan EM, Chen Y, Chan EKL. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma. J Hepatol. 2007;46:107–14.

    Article  CAS  PubMed  Google Scholar 

  15. Chen Y, Zhou Y, Qiu S, Wang K, Liu S, Peng XX, et al. Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma. Cancer Lett. 2010;289:32–9.

    Article  CAS  PubMed  Google Scholar 

  16. Dai L, Ren P, Liu M, Imai H, Tan EM, Zhang JY. Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma. Clin Immunol. 2014;152:127–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Gordis L. Assessing the validity and reliability of diagnostic and screening tests. In: Gordis L, editor. Epidemiology. 2nd ed. Philadelphia: Saunders; 2000. p. 63–81.

    Google Scholar 

  18. Chen WQ, Zheng RS, Zeng HM, Zhang SW, Li GL, Wu LY, et al. Incidence and mortality of breast cancer in China, 2008. Thorac Cancer. 2013;4:59–65.

    Article  Google Scholar 

  19. Zeng H, Zheng R, Zhang S, Zou X, Chen W. Incidence and mortality of female breast cancer in China, 2009. Thorac Cancer. 2013;4:400–4.

    Article  Google Scholar 

  20. Anderson KS, LaBaer J. The sentinel within: exploiting the immune system for cancer biomarkers. J Proteome Res. 2005;4:1123–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Zhang JY, Tan EM. Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors. Expert Rev Mol Diagn. 2010;10:321–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The authors thank Dr. Eng M. Tan (The Scripps Research Institute) for his support. This work was supported by a grant (SC1CA166016) from the National Institutes of Health (NIH). We also thank the Border Biological Research Center (BBRC) Core Facilities at The University of Texas at El Paso (UTEP) for their support, which were funded by an NIH grant (5G12MD007592).

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Clinical Laboratory Technology, Dalian Municipal Central Hospital, Dalian, 116033, Liaoning, China

    Weihong Liu & Bo Wang

  2. Department of Biological Sciences, University of Texas at El Paso, 500 West University Avenue, El Paso, TX, 79968, USA

    Weihong Liu, Bo Wang, Yuan Liu, Liping Dai, Wei Qian & Jian-Ying Zhang

  3. Department of Immunology and Rheumatology, Hospital General de Occidente and University of Guadalajara, Guadalajara, Jalisco, Mexico

    Ignacio García De La Torre & María Cristina Gutiérrez-Rivera

  4. College of Sino-Dutch Biomedical and Information Engineering, Northeastern University, Shenyang, 110189, Liaoning, China

    Wei Qian & Jian-Ying Zhang

Authors
  1. Weihong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ignacio García De La Torre
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. María Cristina Gutiérrez-Rivera
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bo Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Liping Dai
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wei Qian
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jian-Ying Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Weihong Liu or Jian-Ying Zhang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, W., De La Torre, I.G., Gutiérrez-Rivera, M.C. et al. Detection of autoantibodies to multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer. Tumor Biol. 36, 1307–1312 (2015). https://doi.org/10.1007/s13277-014-2756-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2756-5

Keywords

Search

Navigation